公司资料

Henry Schein 股价、新闻与催化剂

股票代码:
HSIC
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

84.93 USD (+1.14%)

收盘价

最后更新: 2026年10月1日

8.66B USD

市值

股价为何变动

截至 2026年10月1日,HSIC 上涨 1.14%,收于 $84.93。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

Healthcare Products and Services Platform

Henry Schein supplies products, services, and technology to office-based dental and medical practitioners, dental laboratories, institutional clinics, and other alternate-care sites. Its scale combines a broad product catalog with advisory, operational, and clinical support.

Dental Distribution and Equipment

The company distributes dental consumables, instruments, equipment, and digital workflow systems. It also supports equipment installation, repair, practice transitions, and other services that deepen its relationships with dental offices and laboratories.

Medical Distribution

Henry Schein serves physician practices, ambulatory surgery centers, urgent-care facilities, and other non-hospital settings with pharmaceuticals, vaccines, diagnostics, equipment, and routine medical supplies.

Specialty Products

The specialty portfolio includes dental implants, endodontic products, orthodontic solutions, and other clinically differentiated offerings. These products complement the core distribution business and give the company greater exposure to procedure-driven categories.

Technology and Value-Added Services

Henry Schein provides practice-management software, revenue-cycle services, financial solutions, consulting, and other tools intended to improve clinical and administrative workflows. A centralized, automated distribution network supports more than 300,000 branded and private-label products.

未来催化剂

    近期新闻

    新闻标题由机器翻译,详情为英文原文。

    1. 01

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。